HORSHAM, Pa.–(BUSINESS WIRE)–NMS Labs, a national leader in forensic and clinical toxicology services, is pleased to announce the promotion of Gregory Schuh to Chief Financial Officer, effective July 21, 2026. His promotion reflects NMS Labs’ continued investment in operational excellence, financial stewardship, and commercial growth.
Greg joined NMS Labs in April 2023 as Controller. In this role, he oversaw the organization’s finance and accounting functions, supporting both day-to-day operations and long-term financial strategy. Since joining NMS Labs, Greg has led finance and procurement automation initiatives and modernized the company’s internal business reporting structure.
“Greg brings more than 20 years of financial leadership experience across public and private organizations. His deep experience in financial operations, finance technology, financial planning and analysis (FP&A), and strategic finance provide key leadership skills as NMS Labs evolves into our next phases of growth and impact,” said Dave Delia, Chief Executive Officer of NMS Labs.
Before joining NMS Labs, Greg spent two decades in senior financial leadership roles within the financial services and financial technology sectors.
ABOUT NMS LABS
NMS Labs is a leading bioanalytical toxicology and forensic sciences laboratory providing esoteric clinical and forensic services to physicians, attorneys, the criminal justice system, clinical reference labs, pharmaceutical companies, and consumer products manufacturers. As part of our services, professionals from NMS Labs interpret our laboratory testing results to resolve client-specific issues and provide expert witness testimony and consulting support for both civil and criminal judicial proceedings.
Website: nmslabs.com
Follow NMS Labs on Social Media
LinkedIn – https://linkedin.com/company/nms-labs
Facebook – https://www.facebook.com/NMSLABSs/
X – https://x.com/NMS_Labs
Contacts
Karen Weed – Vice President Commercial Marketing
Tel: 608 419 0770
